← back to search

Hengrui Liu

Sun Yat-sen University Cancer Center · CN
Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Biology, Medicine, Cancer, Helicobacter pylori, Gene, and Biomarker.
h-index
citations
1,101
works
20
NIH funding
primary concept
email

Recent publications

Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers
PLoS ONE 2025cited by 43position: firstdoi
The Recent Changing Global Landscape of Cancer
Life Conflux 2025cited by 8position: lastdoi
Bridging Discovery and Treatment: Cancer Biomarker
Cancers 2025cited by 4position: firstdoi
Autophagy in <scp>PE</scp> : Dispute, Role and Potential Target
Cell Proliferation 2025cited by 4position: middledoi
<i>Exocarpium Citri Grandis</i> Ameliorates Metabolic Disorders by Inhibiting Inflammatory Responses and NLRP3 Inflammasome Activation
Food Science & Nutrition 2025cited by 3position: middledoi
Network Perturbation Analysis Identifies Three Molecular Subtypes With Distinct Clinical Outcomes and Therapeutic Vulnerabilities in Endometrial Cancer
iMetaMed 2025cited by 0position: middledoi
Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer
Heliyon 2024cited by 66position: middledoi
Identification of molecular targets of Hypericum perforatum in blood for major depressive disorder: a machine-learning pharmacological study
Chinese Medicine 2024cited by 50position: lastdoi
1,3,6-Trigalloylglucose: A Novel Potent Anti-Helicobacter pylori Adhesion Agent Derived from Aqueous Extracts of Terminalia chebula Retz
Molecules 2024cited by 46position: middledoi
Chebulinic acid isolated from aqueous extracts of Terminalia chebula Retz inhibits Helicobacter pylori infection by potential binding to Cag A protein and regulating adhesion
Frontiers in Microbiology 2024cited by 40position: middledoi
Pan-cancer genetic analysis of disulfidptosis-related gene set
Cancer Genetics 2023cited by 152position: firstdoi
MAPK signaling pathway-based glioma subtypes, machine-learning risk model, and key hub proteins identification
Scientific Reports 2023cited by 90position: firstdoi
A bioinformatic study of IGFBPs in glioma regarding their diagnostic, prognostic, and therapeutic prediction value.
PubMed 2023cited by 70position: first
Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway
Journal of Ethnopharmacology 2023cited by 61position: middledoi
Syzygium aromaticum enhances innate immunity by triggering macrophage M1 polarization and alleviates Helicobacter pylori-induced inflammation
Journal of Functional Foods 2023cited by 55position: middledoi
Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set
Frontiers in Oncology 2022cited by 171position: firstdoi
Potential roles of Cornichon Family AMPA Receptor Auxiliary Protein 4 (CNIH4) in head and neck squamous cell carcinoma
Cancer Biomarkers 2022cited by 98position: firstdoi
Potential Therapeutic Application of Local Anesthetics in Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery 2022cited by 62position: middledoi
A randomized, double-blinded, superiority clinical trial to compare two dimensions of traditional medical precision medicine for allergic rhinitis: syndrome differentiation-based treatment or staging treatment?
Research Square 2022cited by 0position: lastdoi
Potential Roles of Cornichon Family AMPA Receptor Auxiliary Protein 4 (CNIH4) in Head and Neck Squamous Cell Carcinoma
Research Square 2021cited by 16position: middledoi
Changes in related circular RNAs following ERβ knockdown and the relationship to rBMSC osteogenesis
Biochemical and Biophysical Research Communications 2017cited by 66position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ling Ou · Jiangxi University of Traditional Chinese Medicine6 papers (2017–2024)Zhong Feng · Luye Pharma (China)5 papers (2023–2024)Tao Tang · National Medical Products Administration5 papers (2022–2025)Yuanjing Zou · Nanjing Agricultural University4 papers (2023–2024)Chang Peng · Jiangxi University of Traditional Chinese Medicine4 papers (2023–2024)Guimin Zhang · Second Military Medical University4 papers (2023–2024)Yixue Li · King University3 papers (2021–2022)Meicun Yao · Sun Yat-sen University3 papers (2023–2024)Zhixiang Zhu · Shanxi Medical University3 papers (2023–2024)Qingchang Chen · National University of Singapore2 papers (2024–2024)Yajie Hao · Shanxi Medical University2 papers (2024–2024)Panpan Wang · Wenzhou Medical University2 papers (2024–2025)Qingwei Li · South China Agricultural University2 papers (2024–2024)Meiyun Chen · Guangdong University of Technology2 papers (2023–2024)Yanhua Wang · First Affiliated Hospital of Henan University2 papers (2023–2024)Yuqian Lai · Sun Yat-sen University2 papers (2023–2024)Ilayda Karsidag · University of San Diego2 papers (2025–2025) · 1 papers (2022–2022)Jun Lin · Fujian Medical University1 papers (2022–2022)Xu‐Feng Huang · University of Birmingham1 papers (2025–2025)